Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Omipalisib | 0.0016596 | uM | 4 | 156.25 | 63.10 | 65.00 | 77.75 | 0.8360 | 0.1033 |
SK-BR-3 | Palbociclib | 0.31623 | uM | 4 | 156.25 | 63.10 | 48.00 | 77.75 | 0.6174 | -0.5969 |
SK-BR-3 | Taxol | 0.1 | uM | 4 | 156.25 | 63.10 | 73.00 | 77.75 | 0.9389 | 0.6222 |
SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 75.00 | 77.75 | 0.9646 | 0.7746 | |
SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 46.00 | 77.75 | 0.5916 | -0.6500 | |
SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 69.00 | 77.75 | 0.8875 | 0.3453 | |
SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 68.00 | 77.75 | 0.8746 | 0.2817 | |
SK-BR-3 | Methotrexate | 0.31623 | uM | 4 | 156.25 | 63.10 | 95.00 | 77.75 | 1.2219 | 2.8908 |
SK-BR-3 | Palbociclib | 19.9526 | uM | 4 | 156.25 | 63.10 | 120.00 | 77.75 | 1.5434 | 7.4526 |
SK-BR-3 | Methotrexate | 0.0016596 | uM | 4 | 156.25 | 63.10 | 93.00 | 77.75 | 1.1961 | 2.6254 |
SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 83.00 | 77.75 | 1.0675 | 1.4847 | |
SK-BR-3 | Taxol | 0.31623 | uM | 4 | 156.25 | 63.10 | 60.00 | 77.75 | 0.7717 | -0.1542 |
SK-BR-3 | Palbociclib | 0.01 | uM | 4 | 156.25 | 63.10 | 62.00 | 77.75 | 0.7974 | -0.0569 |
SK-BR-3 | Taxol | 1 | uM | 4 | 156.25 | 63.10 | 81.00 | 77.75 | 1.0418 | 1.2914 |
SK-BR-3 | Taxol | 0.0031623 | uM | 4 | 156.25 | 63.10 | 63.00 | 77.75 | 0.8103 | -0.0055 |
SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 73.00 | 77.75 | 0.9389 | 0.6222 | |
SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 67.00 | 77.75 | 0.8617 | 0.2201 | |
SK-BR-3 | Palbociclib | 0.031623 | uM | 4 | 156.25 | 63.10 | 52.00 | 77.75 | 0.6688 | -0.4742 |
SK-BR-3 | Methotrexate | 0.0033113 | uM | 4 | 156.25 | 63.10 | 94.00 | 77.75 | 1.2090 | 2.7565 |
SK-BR-3 | Methotrexate | 1 | uM | 4 | 156.25 | 63.10 | 80.00 | 77.75 | 1.0289 | 1.1988 |
SK-BR-3 | Omipalisib | 0.1 | uM | 4 | 156.25 | 63.10 | 65.00 | 77.75 | 0.8360 | 0.1033 |
SK-BR-3 | Taxol | 0.001 | uM | 4 | 156.25 | 63.10 | 59.00 | 77.75 | 0.7588 | -0.2002 |
SK-BR-3 | Omipalisib | 0.31623 | uM | 4 | 156.25 | 63.10 | 59.00 | 77.75 | 0.7588 | -0.2002 |
SK-BR-3 | Omipalisib | 0.031623 | uM | 4 | 156.25 | 63.10 | 43.00 | 77.75 | 0.5531 | -0.7203 |
SK-BR-3 | Methotrexate | 10 | uM | 4 | 156.25 | 63.10 | 57.00 | 77.75 | 0.7331 | -0.2867 |